Works matching IS 09414355 AND DT 2010 AND VI 18 AND IP 3


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

    Published in:
    2010
    By:
    • Kearns AE;
    • Northfelt DW;
    • Dueck AC;
    • Atherton PJ;
    • Dakhil SR;
    • Rowland KM Jr;
    • Fuloria J;
    • Flynn PJ;
    • Dentchev T;
    • Loprinzi CL;
    • Kearns, Ann E;
    • Northfelt, Donald W;
    • Dueck, Amylou C;
    • Atherton, Pamela J;
    • Dakhil, Shaker R;
    • Rowland, Kendrith M Jr;
    • Fuloria, Jyotsna;
    • Flynn, Patrick J;
    • Dentchev, Todor;
    • Loprinzi, Charles L
    Publication type:
    journal article
    15
    16
    17